Dr. Hetty Carraway: 2026 Distinguished Faculty Award Spotlight

Dr. Hetty Carraway, Vice Chair of Strategy and Enterprise Development at Cleveland Clinic’s Taussig Cancer Institute, has been named a 2026 recipient of the Binaytara Distinguished Faculty Award. Recognized for her national leadership in hematologic malignancies and her transformative role in shaping the Nashville Summit on Hematologic Malignancies, Dr. Carraway exemplifies excellence in oncology education, mentorship, and innovation. Selected from more than 700 faculty collaborators, she is being honored for her long-standing commitment to advancing cancer education and expanding access to high-quality learning opportunities for healthcare professionals nationwide.

Dr. Hetty Carraway is one of the 2026 recipients of the Binaytara Distinguished Faculty Award. Selected from more than 700 faculty members with whom Binaytara has worked over the past year, this award honors individuals who have demonstrated long-standing excellence in teaching and have made significant contributions to Binaytara’s educational activities, enhancing access to education for healthcare providers. She is among the honorees celebrated at the Binaytara Annual Gala, held in conjunction with the Nashville Summit on Hematologic Malignancies

Meet Dr. Hetty Carraway

A hematologic oncologist at the Cleveland Clinic’s Taussig Cancer Institute, Dr. Carraway serves as Vice Chair of Strategy and Enterprise Development. She is nationally recognized for her expertise in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndromes (MDS).

Her dual role as both abstract committee co-chair and conference co-chair has been instrumental in shaping Binaytara’s Nashville Summit into a tier-one educational experience, allowing oncologists across the country to benefit from her translational research insights and clinical acumen.

Dr. Carraway’s commitment to advancing the field is evidenced by her numerous peer-reviewed publications and her work with leading organizations, including ASH, AACR, and ASCO, making her an invaluable partner in Binaytara’s mission to elevate oncology care and education.

Dr. Hetty Carraway on Empowering the Next Generation of Oncologists Through Education

For Dr. Carraway, receiving this recognition alongside Dr. Martha Mims and Dr. Deepti Behl is a true honor.

She sees the award as deeply connected to her core beliefs about medicine, teaching, and community. “I feel fortunate to be an oncologist and believe in the dedication to medical education and hope that it will lead to a better future for all patients diagnosed with cancer,” she reflects.

Dr. Carraway holds an unwavering belief in younger generations and their capacity to transform cancer care. She views education and learning as essential to delivering the best possible outcomes for patients.

Perhaps most telling is her belief in the power of community, a space where questions are welcomed, and curiosity is encouraged. In her view, this kind of environment not only fuels innovation but also ensures that clinicians are equipped with the practical knowledge they need to care for others.

Dr. Hetty Carraway's Impact on Binaytara's Nashville Summit on Hematologic Cancers

Dr. Carraway’s relationship with Binaytara began with a single invitation. “My first interaction with Binaytara was when I gave an invited presentation at their Hematologic Malignancies Meeting in Nashville, Tennessee,” she recalls. That first meeting planted seeds that would grow into a long-standing partnership. Year after year, she returned, eventually being invited to serve as co-chair of the National Summit on Hematologic Cancers alongside Dr. Shaji Kumar of Mayo Clinic, Dr. Nitin Jain of MD Anderson Cancer Center, and Dr. Navneet Majhail of Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial.

What began as a speaking invitation has evolved into a leadership role that shapes the content, caliber, and direction of one of Binaytara’s flagship educational programs.

Dr. Carraway engaging with attendees at the 2025 Summit on Hematologic Cancers

Why Medical Education Is the Foundation of Better Cancer Outcomes

When asked to reflect on her most memorable contribution, Dr. Carraway did not point to a lecture or a curriculum milestone, but to something more enduring: the people.

“The most impactful experience of these educational programs is the people and the community we build together.”

She speaks passionately about Binaytara’s mission to deliver high-quality cancer care to all patients and to reduce cancer health disparities, including its ambitious vision to build a hospital in Nepal and serve communities in need. “The mission to build a hospital in Nepal and reach communities in need is an amazing vision,” she says, adding her belief that every contribution, no matter its scale, matters in the pursuit of that goal.

What Drives Dr. Hetty Carraway's Commitment to Oncology Education

Looking forward, Dr. Carraway carries a clear and compelling dream for the next 5 to 10 years in cancer care.

“I dream of a time when we can ensure high-quality cancer care to patients in need, irrespective of where they are located.”

She is clear-eyed about the barriers that remain: delays in time to diagnosis, uneven access to medications, and systemic hurdles that slow the path to treatment. But her resolve to overcome them is equally evident. “I hope we can continue to decrease these disparities and align the mission to deliver care to all patients in need,” she says. It is a vision that aligns seamlessly with Binaytara’s own, and one that will continue to drive her contributions to the organization for years to come.

Join Us in Honoring Dr. Hetty Carraway at Binaytara’s Annual Gala

Our recognition awards reflect the compassionate, scholarly, and community-driven spirit of Binaytara. We will celebrate the awardees at our annual Binaytara gala at SCHD26. To attend this event, register for SCHD26 here.